PlainRecalls
FDA Drug Moderate Class II Terminated

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)

Reported: October 12, 2022 Initiated: September 27, 2022 #D-0003-2023

Product Description

Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton)

Reason for Recall

Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.

Details

Recalling Firm
Pfizer Inc.
Units Affected
103,150 10 mL vials
Distribution
Distributed in the United States and Puerto Rico.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Aminophylline Injection, USP 250 mg/10 mL (25 mg/mL) 25x10 mL Single-dose vial, Rx only, Distributed by Hospira, Inc. Lake Forest, IL 60045 USA. NDC 0409-5921-16 (vial) 0409-5921-01 (carton). Recalled by Pfizer Inc.. Units affected: 103,150 10 mL vials.
Why was this product recalled?
Presence of Particulate Matter: A complaint was received for the presence of a hair in one vial.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 12, 2022. Severity: Moderate. Recall number: D-0003-2023.